BASF ends efforts to acquire Evonik as stock falls 2%

BASF ends efforts to acquire Evonik as stock falls 2%
BASF stock falls 2% to €51.19

BASF announced it is ending its pursuit of Evonik, citing a disciplined approach to capital allocation. Shares are down 2% on the day at €51.19.

BAS price prediction
24H -0.08%
€51.15
48H 0.08%
€51.23
7D -0.59%
€50.89
1M 3.97%
€53.22
3M 8.44%
€55.51
6M 23.36%
€63.15
12M 19.63%
€61.24
Current price: €51.19 -1.0500 2.01%
Closed 11/18
Daily range 51.19 Arrow from to Icon 52.09
Weekly range 51.19 Arrow from to Icon 55.09
Loading...

Highlights

  • BASF ended its pursuit of an Evonik acquisition, reiterating a disciplined approach to capital allocation and dealmaking.
  • Shares are down 2% on the day at €51.19.
  • Of 78 analysts covering BASF, 35 rate the stock a buy and 19 rate it a sell, with a median price target of $55.

BASF announced it will no longer pursue an acquisition of Evonik. The company reiterated its commitment to a disciplined approach in allocating capital. BASF had been preparing an improved offer exceeding €11 billion after Evonik rebuffed an earlier bid, according to Investing.com.

Near-term pressure as BASF holds above key moving average

Stoch RSI is in oversold territory, a stretched reading that limits room for further downside. Shares of BASF are trading within a split daily structure, as price sits below the MA-20 and MA-50 but remains above the MA-200 at €50.89. This setup highlights near-term pressure while still holding longer-term technical support.

Odds tilt to further downside as buyers lack follow-through

A close above €52.38 would show buyers are willing to follow through on the recent move. Stoch RSI remains in oversold territory, suggesting downside from here may be limited. Over the next five trading days, there is a 33% probability of upside versus a 67% chance of further downside, with an expected trading range between €49.44 and €52.93. Still, a drop below €50.89 would show the move is being faded. On the weekly chart the longer-term picture stays constructive.

Previously it was reported that BASF was exploring renewed approaches to acquire Evonik engaging with key stakeholders to address concerns over employment and industrial sites. The decision to end pursuit of the takeover adds a new dimension to the outlook, making the €50.89 level a critical support to monitor for any deterioration in the technical setup.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.